MONICA LAWSON: Open Payments
NPI 1538614128 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,298 in 208 payments from 23 companies in 2025. Trend: 2023 $3,280 · 2024 $3,463 · 2025 $4,298
Food & beverage: $4,298
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 41 | $934 |
| GlaxoSmithKline, LLC. | 46 | $608 |
| Insmed, Inc. | 21 | $482 |
| GENZYME CORPORATION | 13 | $349 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $289 |
| Merck Sharp & Dohme LLC | 7 | $241 |
| Amgen Inc. | 10 | $179 |
| Viatris Specialty LLC | 13 | $171 |
| United Therapeutics Corporation | 6 | $168 |
| Pulmonx Corporation | 4 | $146 |
Products named: DUPIXENT, Arikayce, BREZTRI, TRELEGY ELLIPTA, FASENRA, OFEV, WINREVAIR, AIRSUPRA.
Industry payments across OK — which companies pay providers there.
